|
SYT11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.435100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.476090E-02 |
| Normal-vs-Stage2 |
3.647800E-01 |
| Normal-vs-Stage3 |
3.024200E-01 |
| Normal-vs-Stage4 |
8.56389958947545E-10 |
| Stage1-vs-Stage2 |
6.435200E-01 |
| Stage1-vs-Stage3 |
7.514800E-01 |
| Stage1-vs-Stage4 |
2.24349999999873E-06 |
| Stage2-vs-Stage3 |
8.860400E-01 |
| Stage2-vs-Stage4 |
3.400900E-03 |
| Stage3-vs-Stage4 |
8.262300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.312230E-02 |
| Normal-vs-AfricanAmerican |
2.322000E-01 |
| Normal-vs-Asian |
1.541000E-03 |
| Caucasian-vs-AfricanAmerican |
6.317200E-01 |
| Caucasian-vs-Asian |
3.041800E-02 |
| AfricanAmerican-vs-Asian |
2.727700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50350000005517E-06 |
| Normal-vs-Female |
5.614400E-02 |
| Male-vs-Female |
1.41200000003394E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.083600E-01 |
| Normal-vs-Extreme_Weight |
1.415970E-03 |
| Normal-vs-Obese |
1.099760E-01 |
| Normal-vs-Extreme_Obese |
2.971800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.328600E-01 |
| Normal_Weight-vs-Obese |
8.484200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.252600E-01 |
| Extreme_Weight-vs-Obese |
2.418600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.337400E-01 |
| Obese-vs-Extreme_Obese |
8.894000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.296090E-03 |
| Normal-vs-Age(41-60Yrs) |
3.030800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.681000E-03 |
| Normal-vs-Age(81-100Yrs) |
3.5014999999472E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.536500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.316000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.578000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.658620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.233340E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.839800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.16149999999748E-05 |
| Normal-VS-Type2 PRCC |
2.630400E-01 |
| Normal-VS-KIRP CIMP |
7.43119998869446E-09 |
| Normal-VS-Unclassified PRCC |
1.353150E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.377430E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.567200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.899230E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.541810E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.774500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.04140000000086E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.394000E-01 |
| Normal-vs-N1 |
2.363800E-01 |
| Normal-vs-N2 |
8.059200E-01 |
| N0-vs-N1 |
7.331800E-01 |
| N0-vs-N2 |
4.337800E-01 |
| N1-vs-N2 |
4.164000E-01 |
|
|
